162 related articles for article (PubMed ID: 19044294)
1. [Urologist's role in the treatment with new targeted therapies in advanced renal cell carcinoma].
Arango Toro O
Actas Urol Esp; 2008 Oct; 32(9):865-7. PubMed ID: 19044294
[No Abstract] [Full Text] [Related]
2. [Systemic therapy for metastatic renal cell carcinoma].
Kramer MW; Steffens S; von Klot C; Merseburger AS; Kuczyk MA
Aktuelle Urol; 2012 Jul; 43(4):265-8. PubMed ID: 22869498
[TBL] [Abstract][Full Text] [Related]
3. [Treatment of locally advanced renal tumors].
Sánchez Zalabardo D; Millán Serrano JA; De Pablo Cárdenas A; Cuesta Alcalá JA
Actas Urol Esp; 2010 Feb; 34(2):134-41. PubMed ID: 20403277
[TBL] [Abstract][Full Text] [Related]
4. Recent advances in targeted therapy for renal cell carcinoma.
Clark PE
Curr Opin Urol; 2007 Sep; 17(5):331-6. PubMed ID: 17762626
[TBL] [Abstract][Full Text] [Related]
5. [New targets and drugs for treatment of advanced renal cell carcinoma].
Rohde D
Aktuelle Urol; 2005 Apr; 36(2):125-30. PubMed ID: 15902572
[TBL] [Abstract][Full Text] [Related]
6. Protein kinase inhibitors in renal cell carcinoma.
Daste A; Grellety T; Gross-Goupil M; Ravaud A
Expert Opin Pharmacother; 2014 Feb; 15(3):337-51. PubMed ID: 24328606
[TBL] [Abstract][Full Text] [Related]
7. Presurgical targeted therapy with tyrosine kinase inhibitors for advanced renal cell carcinoma: clinical results and histopathological therapeutic effects.
Kondo T; Hashimoto Y; Kobayashi H; Iizuka J; Nishikawa T; Nakano M; Tanabe K
Jpn J Clin Oncol; 2010 Dec; 40(12):1173-9. PubMed ID: 20696817
[TBL] [Abstract][Full Text] [Related]
8. [Not Available].
Aktuelle Urol; 2015 Sep; 46(5):356-7. PubMed ID: 26394083
[No Abstract] [Full Text] [Related]
9. [Era of molecular targeting therapy in RCC].
Uemura H
Nihon Rinsho; 2012 Nov; 70 Suppl 8():480-5. PubMed ID: 23513887
[No Abstract] [Full Text] [Related]
10. How to interpret phase II data for everolimus plus bevacizumab in renal cell carcinoma.
Escudier B
J Clin Oncol; 2010 May; 28(13):2125-6. PubMed ID: 20368540
[No Abstract] [Full Text] [Related]
11. The current status of adjuvant treatment for high-risk renal cell carcinoma.
Hızal M; Şendur MA; Bilgin B; Akıncı MB; Şener Dede D; Yalçın B
Future Oncol; 2017 Oct; 13(23):2017-2020. PubMed ID: 28984480
[No Abstract] [Full Text] [Related]
12. [The pathologist's role in the neoadjuvant strategy of renal-cell carcinoma].
Leroy X; Edeline J; Rioux-Leclercq N
Ann Pathol; 2011 Dec; 31(6):466-71. PubMed ID: 22172119
[TBL] [Abstract][Full Text] [Related]
13. [Metastatic renal cell carcinoma, back to the future].
Martins F; Berthold D
Rev Med Suisse; 2016 May; 12(519):994-8. PubMed ID: 27424427
[TBL] [Abstract][Full Text] [Related]
14. Use of mammalian target of rapamycin inhibitors after failure of tyrosine kinase inhibitors in patients with metastatic renal cell carcinoma undergoing hemodialysis: A single-center experience with four cases.
Omae K; Kondo T; Takagi T; Iizuka J; Kobayashi H; Hashimoto Y; Tanabe K
Hemodial Int; 2016 Jul; 20(3):E1-5. PubMed ID: 26833674
[TBL] [Abstract][Full Text] [Related]
15. [Tyrosine kinase inhibitor as adjuvant treatment of renal cell carcinoma: 1 versus 3].
Penel N
Bull Cancer; 2017 Sep; 104(9):705-706. PubMed ID: 28760312
[No Abstract] [Full Text] [Related]
16. [Recent advancements in the treatment of renal cell carcinoma--focus on international guidelines].
Biró K; Küronya Z
Magy Onkol; 2010 Dec; 54(4):369-76. PubMed ID: 21163768
[TBL] [Abstract][Full Text] [Related]
17. Metastatic renal cell carcinoma: role of mammalian target of rapamycin inhibitors.
Bukowski RM
Clin Genitourin Cancer; 2007 Sep; 5(6):359-61. PubMed ID: 17956708
[No Abstract] [Full Text] [Related]
18. [Renal cell carcinoma management and therapies in 2010].
Albouy B; Gross Goupil M; Escudier B; Massard C
Bull Cancer; 2010; 97():17-28. PubMed ID: 20418201
[TBL] [Abstract][Full Text] [Related]
19. Influence of Prior Tyrosine Kinase Inhibitor on Survival for Patients with Metastatic Renal Cell Carcinoma Treated with Nivolumab or Cabozantinib: Data from a Literature-based Meta-analysis.
Roviello G; Generali D
Eur Urol; 2017 Dec; 72(6):1027-1028. PubMed ID: 28760645
[No Abstract] [Full Text] [Related]
20. Treatment patterns in metastatic renal cell carcinoma: a retrospective review of medical records from US community oncology practices.
Jonasch E; Signorovitch JE; Lin PL; Liu Z; Culver K; Pal SK; Scott JA; Vogelzang NJ
Curr Med Res Opin; 2014 Oct; 30(10):2041-50. PubMed ID: 24983741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
